Ronald F. van Vollenhoven
Ronald F. van Vollenhoven received his M.D. and Ph.D. degrees from the University of Leiden in The Netherlands. After graduating in 1984, he pursued immunology research at Cornell Medical College in New York, followed by residency (specialty training) at Internal Medicine at SUNY, Stony Brook, and a fellowship in rheumatology at Stanford University in Palo Alto, Calif, USA, following which he received ABIM certification in both internal medicine and rheumatology. From 1993 to 1998, Dr. van Vollenhoven held a faculty appointment as an Assistant Professor of medicine at the Division of Immunology and Rheumatology at Stanford University, and since 1995 he has been the Medical Services Chief and Fellowship Director in that division. In 1998, Dr. van Vollenhoven moved to the Karolinska University Hospital in Stockholm, Sweden, with an appointment as a Senior Physician at the Department of Rheumatology, and as an Associate Professor of rheumatology at Karolinska Institute. Dr. van Vollenhoven’s research interests focus around the development and systematic evaluation of biological and immunomodulatory treatments for the rheumatic diseases. With his coworkers, he has established the Stockholm registry for biological therapies (the STURE database) for this purpose, which has supported a number of research projects relating to clinical efficacy, pharmacology, outcomes, and pharmacoeconomics. He has been a Principal Investigator in many clinical trials of novel therapies in the rheumatic diseases, including recent trials with adalimumab, rituximab, abatacept, tocilizumab, and other biologicals, and has published more than 90 original papers, book chapters, and reviews. In 2004, Dr. van Vollenhoven was awarded the Scandinavian Research Foundation Prize for excellence in clinical research in rheumatology. He also served as the Scientific Secretary of the Swedish Rheumatological Society for four years.
Biography Updated on 28 July 2008